- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (66)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (28)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (230)
- Breast Cancer (716)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (154)
- Colon Cancer (164)
- Colorectal Cancer (110)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (6)
- Kidney Cancer (124)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (100)
- Ovarian Cancer (170)
- Pancreatic Cancer (166)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (236)
- Skin Cancer (294)
- Skull Base Tumors (56)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (98)
- Tonsil Cancer (30)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (624)
- Complementary Integrative Medicine (24)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (230)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (122)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (118)
- Molecular Diagnostics (8)
- Pain Management (62)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (892)
- Research (390)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (604)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (404)
- Survivorship (322)
- Symptoms (184)
- Treatment (1772)
Do women with dense breasts need extra cancer screenings?
2 minute read | Published April 15, 2015
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on April 15, 2015
Recent news headlines suggest women with dense breast tissue need specialty care and exams to detect breast cancer.
But Therese Bevers, M.D., medical director of MD Anderson's Lyda Hill Cancer Prevention Center, says the news is ahead of the science.
"We understand that dense breast tissue is associated with an increased risk for breast cancer, but we don't fully understand that risk," Bevers says. "We need more research on how to manage women with dense breast tissue before we can say whether extra screening exams make a difference."
Below, Bevers answers some common questions about dense breasts and screenings.
What does it mean to have dense breasts?
Breast density describes the proportion of the different tissues that make up a woman's breast. Women with dense breasts have more glandular tissue (breast and connective tissue) than fat.
Also, breast density can only be determined by a mammogram. It's not a measure of feel, such as size or firmness.
Why the concern with dense breast tissue?
It can be harder for mammograms to detect abnormalities in women with dense breast tissue because glandular tissue is harder for imaging technologies to see through than fat.
But it's not impossible.
How do you talk to patients with dense breast tissue?
I approach my patients with dense breast tissue the same way I talk to those without.
Screening exams are based on risk, which is independent of breast density. If my patient has dense breast and is at average risk for breast cancer, I don't recommend supplemental screening. There's just no evidence to say whether extra screening makes a difference.
The evidence for extra screening is for women with dense breast tissue and at increased risk for breast cancer. So recommendations are based on risk, not breast density.
If patients are concerned, they can discuss supplemental screening with their health care providers.
If women are concerned, what extra screenings are available?
3D mammography or tomosynthesis is something that I encourage all women to consider. It's not limited to patients at increased risk or with dense breast tissue. Data shows 3D mammography improves detection of breast cancer with fewer false positives.
It's a good imaging tool because it's looking through millimeter slices of breast tissue, not the entire breast tissue. When you look at the tissue in slices, it's easier to detect abnormalities.
Who can get 3D mammography?
Patients can request 3D screening mammography -- it doesn't require a doctor's order. But you should check to make sure it's covered by insurance first. Most health care providers are submitting it to insurance plans, but we don't know if 100% of the cost is covered.
I tell all my patients to consider 3D mammography with the caveat that I don't know if insurance will cover it.
Related Cancerwise Stories

Data shows 3D mammography improves detection of breast cancer with fewer false positives.
Therese Bevers, M.D.
Medical Director
Cancer Prevention Center